Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reuters Business News Schedule at 1500 GMT/11 AM ET

Thu, 19th Apr 2018 16:23

Editor: Steve Orlofsky +1 646 223 6200

Global Picture Desk: +65 6870 3775

Global Graphics Desk: + 65 6870 3595

(All times GMT / ET)

Receive this schedule by email:

http://mediaexpress.reuters.com

TOP STORIES

Allergan moves in as Shire rebuffs $63 bln Takeda bid-sources

LONDON/NEW YORK - Drugmaker Shire has rejected a thirdtakeover bid worth nearly $63 billion from Japan's TakedaPharmaceutical, although talks are continuing, while sources sayAllergan is also in competing negotiations. (SHIRE-M&A/TAKEDAPHARMA-BID (UPDATE 2), moved, by Greg Roumeliotis, Ben Hirschlerand Ben Martin, 550 words)

EXCLUSIVE-China looks to speed up chip plans as U.S. tradetensions boil -sources

BEIJING - China is looking to accelerate plans to developits domestic semiconductor market amid a fierce trade stand-offwith the United States and a U.S. ban on sales to Chinese phonemaker ZTE that has underscored the country's reliance onimported chips. (USA-TRADE/CHINA-CHIPS (EXCLUSIVE), moved, byElias Glenn and Cate Cadell, 600 words)

P&G to buy German Merck's consumer health unit for $4.2 bln

Procter & Gamble Co will acquire the consumer healthbusiness of Merck KGaA for $4.2 billion, giving it vitaminbrands such as Seven Seas and greater exposure to Latin Americanand Asian markets. (MERCK-M&A/P&G (UPDATE 3, PIX), moved, 450words)

MARKETS

Apple, P&G and chip stocks lead Wall St lower

U.S. stock are lower, pulled down by a broad-based slump intechnology stocks from Apple to chipmakers as well as a tumblein consumer staples such as Procter & Gamble. (USA-STOCKS/(UPDATE 3), updated throughout the day, 420 words)

+ See also:

- GLOBAL-MARKETS/ (WRAPUP 4, PIX), updated throughout theday, 830 words

Oil climbs on Saudi price ambitions and U.S. stocks draw

LONDON - Oil prices keep rising to their highest since late2014 as U.S. crude inventories decline, moving closer tofive-year averages, and after sources tell Reuters that topexporter Saudi Arabia aims to push prices even higher.(GLOBAL-OIL/ (UPDATE 7, PIX), updated throughout the day, 430words)

TRADE/ECONOMY

U.S. weekly jobless claims dip in latest week

WASHINGTON - New applications for U.S. unemployment benefitsfell last week, indicating continued job growth after a slowdownin March. (USA-ECONOMY/UNEMPLOYMENT, moved, 340 words)

China says ready to deal with any fallout from U.S. traderow

BEIJING - China is well prepared to handle any negativeeffects from its trade dispute with the United States, thecommerce ministry says, adding that Beijing's tariff hikes onU.S. imports will not have a big impact overall on its domesticindustries. (USA-TRADE/CHINA (WRAPUP 1, TV), moved, by YawenChen and Se Young Lee, 490 words)

Trump, Japan's Abe agree to intensify trade talks

PALM BEACH - U.S. President Donald Trump and Japanese PrimeMinister Shinzo Abe say they have agreed to intensify tradeconsultations between the two longtime allies, with an aim toexpand investment and trade between their countries.(USA-JAPAN/TRADE-IMBALANCES (UPDATE 3), moved, by Steve Holland,500 words)

COMPANIES

As Bon-Ton liquidates, U.S. department stores vie for itsshoppers

With the disappearance of Bon-Ton, which won courtpermission on Wednesday to liquidate, rivals such as Macy's Inc,J.C. Penney Co Inc and Kohls Corp will compete to keep longtimecustomers from turning to discounters like Walmart Inc or onlinejuggernaut Amazon.com Inc. (BON TON STORES-BANKRUPTCY/ (REPEAT),moved, by Tracy Rucinski and Melissa Fares, 480 words)

Nucor profit beats estimates on higher prices, shipments

Nucor Corp reported a higher-than-expected quarterly profitas its shipments and selling price increased, and the company,the No. 1 U.S. steelmaker by market value, forecast asignificant increase in second-quarter profit on a sequentialbasis. (NUCOR-RESULTS/ (UPDATE 1), moved, 210 words)

Market swings knock Blackstone earnings less than feared

Blackstone Group LP, the largest manager of alternativeassets such as private equity and real estate, on Thursdayreported a 20 percent drop in first-quarter earnings per sharebut still beat Wall Street's expectations, as a stock marketslump weighed on the value of its holdings. (BLACKSTONEGROUP-RESULTS/ (UPDATE 1), moved, by Joshua Franklin, 360 words)

China's ZTE removed chief compliance officer before U.S.sanction -source

HONG KONG - ZTE Corp's chief compliance and chief legalofficer was removed from his posts more than a month before theChinese telecom equipment maker was slapped with U.S. sanctionsthis week, a company source with direct knowledge of thesituation told Reuters. (USA-CHINA/ZTE (PIX), moved, by SijiaJiang, 370 words)

+ See also:

- USA-CHINA/ZTE-RIVALS, moved, by Olof Swahnberg and EricAuchard, 770 words

EXCLUSIVE-Facebook to put 1.5 billion users out of reach ofnew EU privacy law

SAN FRANCISCO - If a new European law restricting whatcompanies can do with people's online data went into effecttomorrow, almost 1.9 billion Facebook Inc users around the worldwould be protected by it. The online social network is makingchanges that ensure the number will be much smaller.(FACEBOOK-PRIVACY/EU (UPDATE 1, EXCLUSIVE, PIX), moved, by DavidIngram, 750 words)

Novartis CEO feels heat on U.S. generics, Cosentyx drop

ZURICH - Swiss drugmaker Novartis' first quarterly resultsunder new Chief Executive Vas Narasimhan have been marred by aprized psoriasis treatment that disappointed and a sharp slumpin sales by its U.S. generics unit. (NOVARTIS-RESULTS/ (UPDATE4, PIX), moved, by John Miller, 610 words)

More News
4 Jan 2019 12:09

LONDON MARKET MIDDAY: Miners Keep FTSE Higher Ahead Of US Payrolls

LONDON (Alliance News) - Stocks in London remained higher midday Friday buoyed by miners, confirmed US-China trade talks and positive Chinese economic data.The FTSE 100 index was up 92.54 points,

Read more
6 Dec 2018 17:39

Oncimmune Appoints Former Tusk Therapeutics CFO Matthew Hall To Board

LONDON (Alliance News) - Cancer diagnostics firm Oncimmune Holdings PLC on Thursday said its has appointed former Tusk Therapeutics Ltd Chief Financial Officer Matthew Hall as finance will replace

Read more
5 Dec 2018 17:12

LONDON MARKET CLOSE: Stocks End Lower Amid Global Growth Fears

LONDON (Alliance News) - Stocks in London ended lower on Wednesday as concerns over global growth and trade wars continued to plague investors. The FTSE 100 index closed down 100.92 points, or at

Read more
5 Dec 2018 13:58

UPDATE: Takeda, Shire Secure Deal Approval From Shareholders

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 12:12

LONDON MARKET MIDDAY: Risk-Off Mood As Weak UK Services Adds To Worry

LONDON (Alliance News) - London stocks slid on Wednesday as risk-off sentiment replaced the more upbeat mood at start of the week, with markets in the US and Asia slumping overnight amid global of

Read more
5 Dec 2018 11:19

WINNERS & LOSERS SUMMARY: Ashtead Falls On US Economic Slowdown Worry

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - up 2.7%. Japan's Takeda Pharmaceutical

Read more
5 Dec 2018 08:44

Asian Shares Fall On Trump-Xi Agreement Scepticism, US Treasury Yields

CANBERA (Alliance News) - Asian stocks ended broadly lower on Wednesday amid concerns over trade and worrying signals of economic health after the difference between three- and five-year US yields

Read more
5 Dec 2018 08:40

LONDON MARKET OPEN: Stocks Sink Amid Trade War, US Economy Jitters

LONDON (Alliance News) - With Monday's gains a distant memory, the FTSE 100 shed nearly 100 points at the London open Wednesday amid renewed global trade fears and worries over the strength of

Read more
5 Dec 2018 08:00

Takeda shareholders approve £46bn Shire takeover

(Sharecast News) - Takeda Pharmaceutical shareholders have approved its £46bn takeover of London-listed pharmaceutical group Shire.

Read more
5 Dec 2018 06:58

LONDON MARKET EARLY CALL: FTSE 100 Seen Down 60 Points After NY Fall

LONDON (Alliance News) - Stocks in London are set to open sharply lower on Wednesday following a slump in New York overnight that was tracked by Asian markets, with the optimism seen at the start

Read more
5 Dec 2018 06:43

TOP NEWS: Takeda Shareholders Approve Acquisition Of Shire

SAINT HELIER (Alliance News) - Japan's Takeda Pharmaceutical Co Ltd announced Wednesday its shareholders approved resolutions related to the proposed acquisition of Irish drugmaker Shire said

Read more
5 Dec 2018 04:06

UPDATE 1-Takeda shareholders give nod for $59 bln Shire acquisition

* Deal is the biggest overseas acquisition by Japanese firm * Some had opposed massive debt required for deal * CEO Weber has promised to slash costs (Adds details about Takashi Dec

Read more
5 Dec 2018 03:32

Takeda shareholders approve Shire acquisition - spokesman

TOKYO, Dec 5 (Reuters) - Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, a Takeda spokesman said, creating a global powerhouse with a but

Read more
2 Dec 2018 11:57

Sunday newspaper round-up: US-China, Brexit, Royal Mail, Barclays, Shire

(Sharecast News) - China and the United States have agreed to halt additional tariffs as both nations engage in new trade negotiations with the goal of reaching an agreement within 90 days, the White House said on Saturday after talks between President Donald Trump and President Xi Jinping in Argentina. - Sunday Telegraph

Read more
30 Nov 2018 08:35

Shire Wins European Okay For Takhzyro Drug Ahead Of January Delisting

LONDON (Alliance News) - Shire PLC said Friday its Takhzyro injection has been approved in Europe to treat hereditary angioedema.Takhzyro is a preventative treatment for hereditary a that a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.